Clover Health [CLOV] vs Cigna [CI] Detailed Stock Comparison
Clover Health
NASDAQ
Loading...
Cigna
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Clover Health wins in 5 metrics, Cigna wins in 13 metrics, with 0 ties. Cigna appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Clover Health | Cigna | Better |
|---|---|---|---|
| P/E Ratio (TTM) | -32.37 | 17.06 | Clover Health |
| Price-to-Book Ratio | 3.84 | 2.06 | Cigna |
| Debt-to-Equity Ratio | 0.00 | 76.10 | Clover Health |
| PEG Ratio | 0.11 | 3.76 | Clover Health |
| EV/EBITDA | -27.43 | 9.54 | Clover Health |
| Profit Margin (TTM) | -2.68% | 1.92% | Cigna |
| Operating Margin (TTM) | -2.21% | 3.67% | Cigna |
| EBITDA Margin (TTM) | N/A | 3.67% | N/A |
| Return on Equity | -12.59% | 13.18% | Cigna |
| Return on Assets (TTM) | -4.26% | 3.98% | Cigna |
| Free Cash Flow (TTM) | $33.29M | $8.96B | Cigna |
| Dividend Yield | N/A | 1.37% | N/A |
| 1-Year Return | -35.89% | -8.98% | Cigna |
| Price-to-Sales Ratio (TTM) | 0.83 | 0.32 | Cigna |
| Enterprise Value | $1.13B | $108.86B | Cigna |
| EV/Revenue Ratio | 0.70 | 0.42 | Cigna |
| Gross Profit Margin (TTM) | 20.86% | 8.85% | Clover Health |
| Revenue per Share (TTM) | $3 | $961 | Cigna |
| Earnings per Share (Diluted) | $-0.08 | $18.23 | Cigna |
| Beta (Stock Volatility) | 2.11 | 0.46 | Cigna |
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends
Clover Health vs Cigna Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Clover Health | 1.16% | -19.06% | -2.63% | 1.17% | -26.21% | -17.25% |
| Cigna | -2.58% | 8.68% | 3.50% | -2.74% | -8.11% | 13.30% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Clover Health | -35.89% | 64.97% | -75.50% | -74.61% | -74.61% | -74.61% |
| Cigna | -8.98% | 7.84% | 76.30% | 128.07% | 778.04% | 705.91% |
News Based Sentiment: Clover Health vs Cigna
Clover Health
News based Sentiment: NEGATIVE
October was a turbulent month for Clover Health, dominated by stock declines triggered by regulatory concerns surrounding ACA tax credits and a notable insider sale by the CEO. While institutional investors increased their holdings, the negative sentiment stemming from policy uncertainty and insider activity overshadows these positive developments, making it a significant month for investors to assess the company's risk profile.
Cigna
News based Sentiment: MIXED
Cigna is preparing for a key earnings release while showing innovation and maintaining institutional support, but faces increased short interest and insider selling. This creates a mixed investment picture, making the upcoming earnings report particularly important.
Performance & Financial Health Analysis: Clover Health vs Cigna
| Metric | CLOV | CI |
|---|---|---|
| Market Information | ||
| Market Cap | $1.62B | $83.01B |
| Market Cap Category | Small cap | Large cap |
| 10 Day Avg. Volume | 11,497,670 | 1,641,100 |
| 90 Day Avg. Volume | 7,062,627 | 1,518,637 |
| Last Close | $2.62 | $302.99 |
| 52 Week Range | $2.12 - $4.87 | $256.89 - $358.88 |
| % from 52W High | -46.20% | -15.57% |
| All-Time High | $28.85 (Jun 07, 2021) | $370.83 (Sep 16, 2024) |
| % from All-Time High | -90.92% | -18.29% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.34% | 0.11% |
| Quarterly Earnings Growth | 0.34% | -0.01% |
| Financial Health | ||
| Profit Margin (TTM) | -0.03% | 0.02% |
| Operating Margin (TTM) | -0.02% | 0.04% |
| Return on Equity (TTM) | -0.13% | 0.13% |
| Debt to Equity (MRQ) | 0.00 | 76.10 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $0.67 | $150.84 |
| Cash per Share (MRQ) | $0.39 | $19.26 |
| Operating Cash Flow (TTM) | $-46,732,000 | $5.29B |
| Levered Free Cash Flow (TTM) | $83.15M | $4.47B |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | 1.37% |
| Last 12-Month Dividend | N/A | $4.31 |
Valuation & Enterprise Metrics Analysis: Clover Health vs Cigna
| Metric | CLOV | CI |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | -32.37 | 17.06 |
| Forward P/E | -18.50 | 9.93 |
| PEG Ratio | 0.11 | 3.76 |
| Price to Sales (TTM) | 0.83 | 0.32 |
| Price to Book (MRQ) | 3.84 | 2.06 |
| Market Capitalization | ||
| Market Capitalization | $1.62B | $83.01B |
| Enterprise Value | $1.13B | $108.86B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 0.70 | 0.42 |
| Enterprise to EBITDA | -27.43 | 9.54 |
| Risk & Other Metrics | ||
| Beta | 2.11 | 0.46 |
| Book Value per Share (MRQ) | $0.67 | $150.84 |
Financial Statements Comparison: Clover Health vs Cigna
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | CLOV | CI |
|---|---|---|
| Revenue/Sales | $462.33M | $67.23B |
| Cost of Goods Sold | $353.44M | N/A |
| Gross Profit | $108.89M | N/A |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | $-1.27M | N/A |
| EBITDA | $-808,000 | N/A |
| Pre-Tax Income | $-1.27M | $2.02B |
| Income Tax | N/A | $389.00M |
| Net Income (Profit) | $-1.27M | $1.63B |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | CLOV | CI |
|---|---|---|
| Cash & Equivalents | $155.44M | $8.33B |
| Total Current Assets | $331.41M | N/A |
| Total Current Liabilities | $215.65M | N/A |
| Long-Term Debt | N/A | $26.46B |
| Total Shareholders Equity | $336.08M | $40.41B |
| Retained Earnings | $-2.20B | $44.43B |
| Property, Plant & Equipment | $5.03M | N/A |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | CLOV | CI |
|---|---|---|
| Operating Cash Flow | $-24.27M | $-493.00M |
| Capital Expenditures | $-185,000 | $-327.00M |
| Free Cash Flow | $-16.48M | $1.59B |
| Debt Repayment | N/A | $-700.00M |
| Common Stock Repurchase | $-31.96M | $-1.51B |
Short Interest & Institutional Ownership Analysis
| Metric | CLOV | CI |
|---|---|---|
| Shares Short | 49.28M | 3.26M |
| Short Ratio | 9.76 | 2.18 |
| Short % of Float | 0.12% | 0.02% |
| Average Daily Volume (10 Day) | 11,497,670 | 1,641,100 |
| Average Daily Volume (90 Day) | 7,062,627 | 1,518,637 |
| Shares Outstanding | 503.53M | 273.79M |
| Float Shares | 400.54M | 265.64M |
| % Held by Insiders | 0.04% | 0.02% |
| % Held by Institutions | 0.35% | 0.90% |
Dividend Analysis & Yield Comparison: Clover Health vs Cigna
| Metric | CLOV | CI |
|---|---|---|
| Last 12-Month Dividend | N/A | $4.31 |
| Last 12-Month Dividend Yield | N/A | 1.37% |
| 3-Year Avg Annual Dividend | N/A | $4.35 |
| 3-Year Avg Dividend Yield | N/A | 0.42% |
| 3-Year Total Dividends | N/A | $13.04 |
| Ex-Dividend Date | N/A | Mar 05, 2025 |